RESEARCH, DEVELOPMENT, TEST, AND EVALUATION, AND STRATEGIC INITIATIVES JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL ANDB…
ContractFA807517F1348
This contract is for RESEARCH, DEVELOPMENT, TEST, AND EVALUATION, AND STRATEGIC INITIATIVES JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL AND BIOLOGICAL DEFENSE under the Department of Defense (DOD). The incumbent is MRIGLOBAL with an estimated value of $64.1M. The period of performance ended May 10, 2022. The typical 12–18-month capture window has closed; recompete action is overdue — watch for a follow-on solicitation or bridge, not an upcoming open date. With only one bidder and an upward money direction, the competitive posture is limited. The incumbent's footprint shows significant obligations across multiple agencies, but the single-bidder environment reduces immediate competitive pressure despite the overdue recompete timing.
MRIGLOBAL holds $121.9M across 67 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended May 10, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.
RESEARCH, DEVELOPMENT, TEST, AND EVALUATION, AND STRATEGIC INITIATIVES JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL ANDBIOLOGICAL DEFENSE
Recompete timingPublic
● Past PoP end (1539 days ago)
Current PoP ended May 10, 2022 (1539 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →
Data as of · refreshed monthlyLatest procurement action
